Genitrix

Genitrix is a prominent Spanish biotechnology holding company that specializes in the creation, development, and management of innovative life science firms. Founded in 2001 by a group of scientists from the National Center for Biotechnology (CNB-CSIC), it was a pioneer in the Spanish biotech sector. The group has successfully incubated several high-profile companies, including Cellerix, which developed the first allogeneic stem cell therapy approved in Europe (Alofisel), and X-Pol Biotech, which was acquired for its advanced DNA polymerase technology. Genitrix operates as a venture platform, translating academic research into commercial products across therapeutics, diagnostics, and research tools. The company remains a significant name in European biotech history due to its successful exit strategies and its role in advancing regenerative medicine.